SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma rises on securing Inspection Closure Report from WHO

03 Jun 2026 Evaluate

Bliss GVS Pharma is currently trading at Rs. 442.40, up by 7.65 points or 1.76% from its previous closing of Rs. 434.75 on the BSE.

The scrip opened at Rs. 436.90 and has touched a high and low of Rs. 447.35 and Rs. 429.25 respectively. So far 173815 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 447.35 on 03-Jun-2026 and a 52 week low of Rs. 118.35 on 10-Nov-2025.

Last one week high and low of the scrip stood at Rs. 447.35 and Rs. 265.30 respectively. The current market cap of the company is Rs. 4622.98 crore.

The promoters holding in the company stood at 35.36%, while Institutions and Non-Institutions held 15.49% and 49.15% respectively.

Bliss GVS Pharma has secured an Inspection Closure Report from the World Health Organization (WHO) for its manufacturing facility located in Palghar (East), Maharashtra. The facility has been confirmed to be in compliance with the Good Manufacturing Practices (GMP) standards published by the WHO.

Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.

Bliss GVS Pharma Share Price

456.85 17.45 (3.97%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×